US 12,589,056 B2Grant

Curable composition for dental impression

Issue Date:2026-03-31

•14 Claims

Abstract

The present describes a curable composition for dental impression comprising: a curable base composition and a surfactant system comprising a first surfactant, which is at least one compound having the formula (I) and a second surfactant, which works synergistically with the second surfactant so as to permit the composition to surprisingly have a lower contact angle; these results are reached with relatively low concentrations of biodegradable surfactants.

Metadata

Assignee

DENTSPLY SIRONA Inc.

Inventors

Massimo Rossi
Alberto Basso
Lorenzo Galliera

Application Information

Application Number:US 17/776,280

Filing Date:2020-11-19

Priority Date:2019-11-20

Art Unit:1767

Classifications

IPC:

A61K6/90A61K31/695B01J23/56

Field of Search:

A61K 6/90A61K 31/695A61K 6/896B01J 23/835B01J 23/56B01J 23/14B01J 23/42

Patent Drawings

This patent does not have any drawings.

Description

FIELD OF THE INVENTION

[0001] The present invention relates to a curable composition for dental impression and a use thereof. The present invention also relates to a method of taking an impression.

BACKGROUND OF THE INVENTION

[0002] Room temperature vulcanizing silicone rubbers (RTV) are known as dental impression materials, especially for their mechanical performances and elastic properties. Moreover, addition silicones have a good dimensional stability after days from the impression taking.

[0003] Addition silicones impression materials are usually made by polysiloxanes vinyl terminated and cross linkers having Si—H groups into the chain: they typically react in the presence of a platinum catalyst (hydrosilylation reaction—see e.g. U.S. Pat. No. 7,592,377 B2, Dental Materials and Their selection, William J. O'Brien, Quintessence Publishing Co.—ISBN-13:978-0867154375).

[0004] Another class of impression materials are Condensation silicones impression materials that are normally made by polysiloxanes hydroxy terminated and alkoxysilanes cross linkers: they react usually in the presence of a tin catalyst (see e.g. Dental Materials and Their selection, William J. O'Brien, Quintessence Publishing Co.—ISBN-13:978-0867154375, U.S. Pat. Nos. 4,389,496 A, 5,925,723 A, 6,218,461 B1).

[0005] Fillers and additives are typically added both to addition and condensation silicones to improve their mechanical performances or get specific organoleptic properties.

[0006] In particular, the use of surfactants is known to improve the impression material compatibility with oral tissues. The fluid materials, named extra light, light, regular or monophase, can therefore easily penetrate in the gingival sulcus with a better marginal sulcus detail reproduction.

[0007] The surfactant performance into a dental impression material is evaluated with the contact angle measurement and in particular with the sessile drop method. The use of modified trisiloxane polyalkyleneoxides super spreading surfactants, having the following formula:

[0008]

was reported in U.S. Pat. No. 4,657,959.

[0009] The modified trisiloxane polyalkyleneoxides are a powerful class of surfactants, since they have at the same time a quite high efficacy in reducing the surface tension (˜20 mN/m) and, especially, a very high spread area with respect to other surfactants with a more pronounced effect in reducing the surface tension (Kovalchuk et al, Fluoro vs Hydrocarbon surfactants: why do they differ in wetting performance? Advance in Colloid and Interface Science, Volume 210 (2014), pages 65-71).

[0010] The efficacy as a superspreader is lower when it is englobed in a matrix. This is caused by the lower migration capacity towards the impression material surface.

[0011] The modified trisiloxane polyalkyleneoxides cannot reach the critical wetting concentration (CWC) when they are dispersed into a complicated mixture of ingredients. The CWC is the concentration where these surfactants become superspreader and has been determined by Svitova and others (Langmuir 1998, 14, 5023-5031).

[0012] Some compositions, containing one or more additional surfactants, have been proposed to help the modified trisiloxane polyalkyleneoxides to perform properly and reach easily the impression material surface (see e.g. EP1976479B1, U.S. Pat. No. 7,812,065, DE112007000073, EP2231102B1 ed U.S. Pat. No. 8,466,210).

[0013] US 2008/319100 A1 discloses a dental impression mass containing curable polymers selected from the group of organopolysiloxanes that crosslink by means of an addition reaction, of organopolysiloxanes that crosslink by means of a condensation reaction, of polyethers containing alkoxy silyl radicals that crosslink by means of a condensation reaction, of polyethers containing aziridino radicals that crosslink by means of an addition reaction, of polyethers containing alkenyl radicals that crosslink by means of an addition reaction, of polyethers containing ester radicals of an ethylene-unsaturated carboxylic acid that crosslink by means of a radical polymerization reaction, or of polyethers that crosslink by means of a ring-opening metathesis reaction, silicones, or rubbers, and furthermore containing at least one (poly)alkylene oxide radical as well as one silicon-containing non-ionic surfactant with a molecular mass of less than 6000 g/mol, and a non-ionic fluorosurfactant, that has at least one partially fluoridated or perfluoridated hydrocarbon radical that is connected with a (poly)alkylene oxide radical, a hydrocarbon radical, an aliphatic poly hydroxy radical, or a heterocyclic radical containing nitrogen, by way of an oxygen atom, an amino group, a keto group, a carboxylic acid ester group, a phosphoric acid ester group, a carboxylic acid amide group and/or a phosphoric acid amide group, or that has at least one partially fluoridated or perfluoridated hydrocarbon radical and at least one amino oxide radical.

[0014] US 2019/240118 A1 discloses an impression material comprising a catalyst part and a base part, the catalyst part comprises a curable organopolysiloxane polymer, a catalyst, and at least one filler; the base part comprises a curable organopolysiloxane polymer, an organopolysiloxane compound capable of crosslinking said curable organopolysiloxane polymer, at least one filler and a combination of surfactants; wherein the combination of surfactants of the base part includes fluoroaliphatic polyoxyethylene type surfactant, and a monofunctional alcohol alkoxylate type surfactant; wherein the fiuoroaliphatic polyoxyethylene type surfactant is a C6 perfluorinated aliphatic chain bonded to a polyoxyethylene fragment giving an overall molecular weight range of from 400 to 800; and wherein the monofunctional alcohol alkoxylate type surfactant is of one respective formula as given in claim 1 of said document.

[0015] US 2011/1118378 A1 discloses a composition containing curable polymers is disclosed selected from the group of organopolysiloxanes that crosslink by means of an addition reaction, organopolysiloxanes that crosslink by means of a condensation reaction, polyethers that contain alkoxysilyl groups and crosslink by means of a condensation reaction, polyethers that contain aziridino groups and crosslink by means of an addition reaction, polyethers that contain alkenyl groups and crosslink by means of an addition reaction, polyethers that contain ester groups of an ethylenically unsaturated carboxylic acid and crosslink by means of a radical polymerization reaction, or polyethers, silicones or rubbers that crosslink by means of a ring-opening metathesis reaction and also contain at least one nonionic and/or ionic fluorosurfactant as given in claim 1 of said document as well as also containing at least one nonionic surfactant having silicon-containing groups with a molecular weight of less than 6000 g/mol.

[0016] However, the compositions proposed so far have some drawbacks, among which the following are hereby cited: the concentration of the modified trisiloxane polyalkyleneoxides (in particular, when it is used alone) needs to be relatively high; the proposed additional surfactant/s has/have a negative environmental impact, not being biodegradable; and the contact angles obtained are not always satisfactory.

Objective of the Present Invention

[0017] It is an object of the present invention to provide a curable composition for dental impression, a use of a dental composition and a method of taking an impression, designed to at least partially overcome the aforementioned drawbacks, and which, in particular, are cheap and easy to produce and/or implement.

SUMMARY OF THE INVENTION

[0018] According to the present invention, a curable composition for dental impression, a use of a dental composition and a method of taking an impression are provided, as recited in the following independent claims and, preferably, in any one of the claims directly or indirectly depending on the independent claims.

[0019] Unless explicitly specified to the contrary, the following terms have the meaning indicated below.

[0020] In the present text “aliphatic” means a non-aromatic and non-substituted (radical) hydrocarbon (unless the contrary is specified), saturated or unsaturated, linear, branched and/or cyclic. Non-limiting examples of aliphatic groups are: t-butyl, ethenyl, 1- or 2-propenyl, cyclohexyl.

[0021] In the present text, C_x-C_yrefers to a group that is meant as having from x to y carbon atoms.

[0022] In the present text “alkyl” means a saturated aliphatic (i.e., an aliphatic group without double or triple carbon-carbon bonds). Non-limiting examples of alkyls are: methyl, n-propyl, t-butyl, cyclohexyl.

[0023] In the present text “perfluorinated” compound (PFC) (or “polyfluoroalkyl” chemical) is an organofluorine compound (radical) containing only carbon-fluorine bonds and C—C bonds (no C—H bonds).

[0024] In the present text, “alkoxy” means an alkyl containing an oxygen which is bonded to two carbons.

DETAILED DESCRIPTION OF THE INVENTION

[0025] In accordance with a first aspect of the present invention, there is provided a curable composition for dental impression comprising:

- [0026] a curable base composition and a surfactant system comprising a first surfactant, which has (is at least one compound having) the following formula (I)

[0027]

- [0028] wherein R are each, independently of one another, a C₁-C₄aliphatic; (each) R¹is (independently of the others) a C₁-C₆aliphatic; (each) R²is (independently of the others) selected from a group consisting of: H and C₁-C₃aliphatic; (each) R³is selected (independently of the others) from a group consisting of: H and C₁-C₄aliphatic; x is an integer from 0 to 5; y is an integer from 1 to 10; a is an integer from 1 to 30; b is an integer from 0 to 5.

[0029] Advantageously but not necessarily, R is a methyl. In addition or alternatively, (each) R¹is —C₃H₆—. In addition or alternatively, (each) R²is an —H. In addition or alternatively, (each) R³is selected (independently of the others) from a group consisting of: —H and a methyl; in particular, (each) R³is a methyl. In addition or alternatively, x is an integer from 0 to 1 (in particular, x is zero). In addition or alternatively, y is an integer from 1 to 5 (in particular, y is 1 or 2; more in particular, y is 1). In addition or alternatively, a is an integer from 5 to 20 (in particular, a is 6 to 8; more in particular a is 7). In addition or alternatively, b is zero.

[0030] The surfactant system further comprises a second surfactant, which, according to some non-limiting embodiments, has (is at least one compound having) the following formula (II):

[0031]

- [0032] wherein R⁴is selected from a group consisting of:

[0033]

- [0034] R⁵is selected from a group consisting of:

[0035]

- [0036] and
- [0037] R⁶is selected from a group consisting of:

[0038]

- [0039] wherein k, j, z, r, d and t are each, independently of one another, an integer from 1 to 10; q is an integer from 1 to 100; Rf are each, independently of one another, a C₁-C₆fluorine containing alkyl (in particular, a perfluorinated alkyl); and Rfⁱare each, independently of one another, selected from a group consisting of: CF₃—CF₂—CF₂—O—CF(CF₃)—CH₂— and CF₃—(CF₂)_e—(CH₂)_f—, wherein e is an integer from 1 to 7 and f is an integer from 1 to 10.

[0040] It has been experimentally observed (see examples below) that the first surfactant (I) works synergistically with second surfactant (II) so as to permit the composition to have a surprisingly low contact angle. Please note that these results were achieved with relatively low concentration of the surfactants. In this respect, it has been supposed that the second surfactant increases the migration capacity of the first surfactant towards the impression material surface.

[0041] Moreover, it is important to point out that both the first and the second surfactant (in particular, the second surfactant) are biodegradable and therefore the composition has an environmental impact appreciably more positive with respect to the composition of the state of the art. Inter alia, in this respect, please note that the fluorinated chains of the second surfactant are relatively short.

[0042] Advantageously but not necessarily, k, j, z, r, d and t are each, independently of one another, an integer from 1 to 6, in particular from 1 to 3. In addition or alternatively, q is an integer from 1 to 40, in particular from 1 to 20 (more particularly, q is an integer from 1 to 10). In addition or alternatively, Rf are each, independently of one another, a C₁-C₄fluorine containing alkyl (in particular, a perfluorinated alkyl). In addition or alternatively, and Rfⁱare each, independently of one another, selected from a group consisting of: CF₃—CF₂—CF₂—O—CF(CF₃)—CH₂—, CF₃—(CF₂)₂—(CH₂)— and CF₃—(CF₂)—(CH₂)—.

[0043] According to some non-limiting embodiments, if R⁴represent the structural formula (III), R⁵represents the structural formula (V) and R⁶represents the structural formula (VII). In addition or alternatively, if R⁵represent the structural formula (V), R⁴represents the structural formula (III) and R⁶represents the structural formula (VII). In addition or alternatively, if R⁶represents the structural formula (VII), R⁵represents the structural formula (V) and R⁴represents the structural formula (III).

[0044] In some specific and non-limiting cases, R⁴represents the structural formula (III); R⁵represents the structural formula (V); and R⁶represents the structural formula (VII). These types of compounds are also disclosed US2017/0217863.

[0045] According to some non-limiting embodiments, if R⁴represent the structural formula (IV), R⁵represents the structural formula (VI) and R⁶represents the structural formula (VIII). In addition or alternatively, if R⁵represent the structural formula (VI), R⁴represents the structural formula (IV) and R⁶represents the structural formula (VIII). In addition or alternatively, if R⁶represents the structural formula (VIII), R⁵represents the structural formula (VI) and R⁴represents the structural formula (IV).

[0046] In some specific and non-limiting cases, R⁴represents the structural formula (IV); R⁵represents the structural formula (VI); and R⁶represents the structural formula (VIII). These type of compounds are also disclosed US2013/0269568.

[0047] According to specific and non-limiting embodiments, the second surfactant is selected in the group consisting of: Tividia FL2500, Tividia FL2300, Tividia FL3000 and a combination thereof. In some cases, the second surfactant is selected in the group consisting of: Tividia FL2500, Tividia FL2300 and a combination thereof. In particularly advantageous embodiments, the second surfactant comprises (is) Tividia FL2500.

[0048] Advantageously but not necessarily, the curable composition comprises from approximately 0.1% (in particular, from approximately 1%), in particular to approximately 7% (in particular, to approximately 6%) in weight, with respect to the total weight of the curable composition, of the first surfactant.

[0049] Advantageously but not necessarily, the curable composition comprises from approximately 0.1% (in particular, from approximately 0.3%; more in particular, from approximately 0.5%), in particular to approximately 7% (in particular, to approximately 5%; more in particular, to approximately 3%) in weight, with respect to the total weight of the curable composition, of the second surfactant.

[0050] Advantageously but not necessarily, the curable base composition comprises (in particular, consists of) a first component, comprising a (in particular, consisting of at least one) curable organopolysiloxane polymer; a second component, comprising a (in particular, consisting of at least one) a crosslinker compound capable of crosslinking said organopolysiloxane polymer; and (optionally) a third component, comprising (in particular, consisting of) a catalyst capable of catalysing a crosslinking reaction of the first component and the second component.

[0051] According to some non-limiting embodiments, the third component is a Platinum or Tin comprising catalyst.

[0052] Advantageously but not necessarily, the curable composition comprises at least approximately 0.005% (more precisely, from approximately 0.01%), in particular up to approximately 5% (more precisely, to approximately 2%) in weight, with respect to the total weight of the curable composition, of the catalyst.

[0053] According to a first category of embodiments (in particular, when the third component comprises Platinum), the curable composition comprises at least approximately 0.005% (more precisely, from approximately 0.08%), in particular up to approximately 1% (more precisely, to approximately 0.1%) in weight, with respect to the total weight of the curable composition, of the catalyst.

[0054] According to a first category of embodiments (in particular, when the third component comprises Tin), the curable composition comprises at least approximately 0.5% (more precisely, from approximately 0.8%), in particular up to approximately 3% (more precisely, to approximately 2%) in weight, with respect to the total weight of the curable composition, of the catalyst.

[0055] According to some non-limiting embodiments, the curable base composition also comprises one or more fillers (e.g. quartz and/or fumed silica and; or precipitated silica and/or zirconium oxide and/or aluminum silicate and/or aluminum hydroxide and/or calcium silicates and/or calcium carbonate). In some cases, the curable composition comprises silicon dioxide (e.g. quartz and/or fumed silica).

[0056] In particular, the curable composition comprises from approximately 25% (in particular, from approximately 30%; more in particular, from approximately 34%) to approximately 55% (in particular, to approximately 50%) in weight, with respect to the total weight of the curable composition, of silicon dioxide.

[0057] According to some non-limiting embodiments, the curable base composition comprises (in particular, consists of) the first component, comprising a (in particular, consisting of at least one) organopolysiloxane with at least two ethylene unsaturated groups; and the second component (a cross-linker), in particular having (at least two, in particular at least three) Si—H groups (into the chain).

[0058] Organopolysiloxanes of this kind advantageously (but not necessarily) have the following formula:
CH₂═CH—(—SiR^AR^BO)_w—SiR^AR^BCH═CH₂

[0059] where R^Aand R^Bare each, independently of one another, a substituted or un-substituted monovalent hydrocarbon (in particular aliphatic) radical.

[0060] R^Aand R^Bcan comprise double bonds.

[0061] Examples of groups R^Aand R^Bare methyl, ethyl, phenyl, vinyl or 3,3,3-trifluoropropyl radical.

[0062] Preferably but not necessarily, at least one of R^Aand R^Bis a methyl.

[0063] The value of integer w is such that the viscosity of the polymer at 23° C. is between 50 cP and 1,000,000 cP. Preferred viscosities are of 200-100,000 cP.

[0064] Silicone oils with different viscosities without vinyl groups can be present as plasticizers.

[0065] In particular, the third component comprises a hydrosilylation catalyst. Said hydrosilylation catalyst can be chloroplatinic acid or a Pt siloxane complex. As an alternative said catalyst can be a metal such as Rh or Pd.

[0066] The total content of SiH in the curable base composition should be such as to ensure the complete reaction of all vinyls present in the curable base composition and, furthermore, the second component (cross-linker) can also be present in slight excess. Preferably but not necessarily, the curable base composition comprises linear or cyclic organopolysiloxanes containing a high concentration of vinyls. The presence of said linear or cyclic organopolysiloxanes containing a high concentration of vinyls has the function of adjusting the reactivity of platinum present in the Catalyst.

[0067] Other substances that can be present in the curable base composition are pigments and colorants, aromatic substances.

[0068] Another possible component is the filler which can be chosen among: extending fillers conferring filling, sliding and appearance properties; and reinforcing fillers with reinforcing function.

[0069] Whereas the first one, i.e. extending fillers, are mineral fillers with BET surface below 50 m²/g such as for instance quartz, calcium carbonate, infusorial earth, iron oxide, aluminum silicates and alumina, the second ones, i.e. reinforcing fillers, consist of fumed silica or precipitated silica with quite high BET surface and generally silanized.

[0070] In some specific and non-limiting cases, the first component (the organopolysiloxane) has a viscosity from approximately 20 cP to approximately 50000 cP (in particular, from approximately 500 cP to approximately 20000 cP).

[0071] In particular, the second component (cross-linker) comprises (in particular, consists of) an organohydrogen siloxane and/or an organohydrogen polysiloxane. According to some non-limiting embodiments, the second component comprises (in particular, consists of) methylhydro-gensiloxane. More precisely, the second component (in particular, the methylhydrogensiloxane) has a viscosity of 10 (in particular, from approximately 50) to approximately 200 (in particular, to approximately 70) cP (even more precisely about 60 cP), According to specific and non-limiting embodiments, the methylhydrogensiloxane has 1 to 10 mmol/g SiH content.

[0072] In particular, the third component is a Platinum comprising catalyst. In these cases, advantageously but not necessarily, the curable composition comprises at least approximately 0.005% (more precisely, from approximately 0.08%), in particular up to approximately 1% (more precisely, to approximately 0.1%) in weight, with respect to the total weight of the curable composition, of the catalyst.

[0073] According to some non-limiting embodiments, the Platinum comprising catalyst comprise (is) Karstedt catalyst.

[0074] Advantageously but not necessarily, the curable composition comprises at least approximately 35% (more precisely, at least approximately 40%), in particular up to approximately 70% (more precisely, up to approximately 65%) in weight, with respect to the total weight of the curable composition, of the first component.

[0075] According to some non-limiting embodiments, the curable composition comprises at least approximately 35% (more precisely, at least approximately 40%), in particular up to approximately 55% (more precisely, up to approximately 50%) in weight, with respect to the total weight of the curable composition, of the first component (organopolysiloxane with at least two ethylene unsaturated groups).

[0076] Advantageously but not necessarily, the curable composition comprises at least approximately 1% (more precisely, at least approximately 5%), in particular up to approximately 20% (more precisely, up to approximately 15%) in weight, with respect to the total weight of the curable composition, of the second component.

[0077] According to some non-limiting embodiments, the curable composition comprises at least approximately 3% (more precisely, at least approximately 5%), in particular up to approximately 15% (more precisely, up to approximately 10%) in weight, with respect to the total weight of the curable composition, of the second component (organohydrogen siloxane and/or organohydrogen polysiloxane).

[0078] The percentages of the different components/ingredients/additives can be varied in order to achieve the best results.

[0079] According to some non-limiting embodiments, the curable base composition comprises in particular, consists of) a first component, comprising a (in particular, consisting of at least one) hydroxy terminated organopolysiloxane; and a second component (a cross-linker) comprising (in particular, consisting of) an alkoxysilane.

[0080] Examples of hydroxy terminated organopolysiloxanes (i.e. organopolysiloxanes that can harden by means of a condensation reaction) are known, for example, from DE 4137698 A1.

[0081] Typically, hydroxy terminated organopolysiloxanes (i.e. organopolysiloxanes that can harden by means of a condensation reaction) are compounds have the following formula (XVI)
HO—SiR*₂—B1-SiR*₂—OH (XVI)

- [0082] wherein, R* are each, independently of one another, a C₁-C₄aliphatic (in particular, alkyl; more in particular, a methyl); B1 stands for a radical having the formula —O—(SiR′₂—O)_m2—, wherein R′ are each, independent of one another, a (in particular C₁-C₆more in particular C₁-C₄) alkyl, alkenyl, alkinyl, cycloalkyl, aryl and/or aralkyl (which might be substituted), and m2 is an integer from 10 to 6000, preferably from 20 to 2000. According to some non-limiting examples, R′ are each, independent of one another, a (in particular C₁-C₆, more in particular C₁-C₄) alkyl (such as a methyl, ethyl, n-propyl, isopropyl or n-butyl).

[0083] Typically, alkoxysilanes are compounds with one of the following formulas (XVII), (XVIII) and (XIX).

[0084]

- [0085] wherein R″ are each, independent of one another, a (in particular C₁-C₆, more in particular C₁-C₄) alkyl, alkenyl, alkinyl, cycloalkyl, aryl and/or aralkyl (which might be substituted); R** are each, independent of one another, a (in particular C₁-C₆, more in particular C₁-C₄) alkyl, alkenyl, alkinyl, cycloalkyl, aryl and/or aralkyl (which might be substituted); m3 is an integer from 1 to 3; m4 is from 0 to 2; B2 stands for a radical having the formula —O—(SiR^1t₂—O)_m5—, R^1tare each, independent of one another, a (in particular C₁-C₆, more in particular C₁-C₄) alkyl, alkenyl, alkinyl, cycloalkyl, aryl and/or aralkyl (which might be substituted); and m5 is an integer from 10 to 6000, preferably from 1 to 2000 (in particular, from 1 to 100; more in particular, from 50 to 70).

[0086] According to some non-limiting examples, R** are each, independent of one another, a (in particular C₁-C₆, more in particular C₁-C₄) alkyl (such as a methyl, ethyl, n-propyl, isopropyl or n-butyl).

[0087] According to some non-limiting examples, R″ are each, independent of one another, a (in particular C₁-C₆, more in particular C₁-C₄) alkyl (such as a methyl, ethyl, n-propyl, isopropyl or n-butyl).

[0088] According to some non-limiting examples, R^1tare each, independent of one another, a (in particular C₁-C₆, more in particular C₁-C₄) alkyl (such as a methyl, ethyl, n-propyl, isopropyl or n-butyl).

[0089] In particular, the third component is a Tin comprising catalyst. In these cases, advantageously but not necessarily, the curable composition comprises at least approximately 0.5% (more precisely, from approximately 0.8%), in particular up to approximately 3% (more precisely, to approximately 2%) in weight, with respect to the total weight of the curable composition, of the catalyst.

[0090] According to some non-limiting embodiments, the Tin comprising catalyst comprises (is) Dibutyl-Tin Dilaurate (IUPAC name [Dibutyl(dodecanoyloxy)stannyl] dodecanoate), Dibutyl-Tin Di-acetate (IUPAC name [acetyloxy(dibutyl)stannyl] acetate), Dioctyl-Tin oxide (IUPAC name Dioctyl(oxo)tin—CAS number 870-08-6) and/or Tin(II) Octanoate (IUPAC name lead(2+) octanoate). In some specific cases, the Tin comprising catalyst comprises (is) Dioctyl-Tin oxide.

[0091] Advantageously but not necessarily, the first component (hydroxy terminated organopolysiloxane) has a viscosity from approximately 500 cP to approximately 80000 cP (in particular, from 1000 cP to approximately 20000 cP).

[0092] Advantageously but not necessarily, the second component (the alkoxysilane) comprises (is) Methyltrimethoxysilane, Methyltriethoxysilane, Ethyltrimethoxysilane, Ethyltriethoxysilane, n-Propyltrimethoxysilane, Tetrakis-(butoxy-ethoxy)silane ((CH₃—(CH₂)₃—O—(CH₂)₂—O)₄—Si), Methyltriacethoxysilane (CAS No.: 4253-34-3).

[0093] According to some non-limiting embodiments, the curable composition comprises from approximately 1% (in particular, from approximately 2%) to approximately 5% (in particular, to approximately 4%) in weight, with respect to the total weight of the curable composition, of the second component (the alkoxysilane).

[0094] All the components referred to above should be combined together in a specific way so as to carry out a material for impression taking, having the necessary rheologic, mechanical, bio-compatibility properties.

[0095] In accordance with further non-limiting embodiments, the second surfactant has (is at least one compound having) the following formula (IX):

[0096]

- [0097] wherein Rfⁱⁱrepresents a C₁-C₆fluorine containing alkyl; R⁷represents a C₁-C₄alkyl; Ra represents a C₁-C₃alkyl; Rb represents a C₁-C₃alkyl; Re is selected in the group consisting of; a C₁-C₆; aliphatic (in particular, alkyl) and a C₁-C₆alkoxy; Rp represents a C₁-C₆, alkyl; ax is an integer from 1 to 10; ay is an integer from 1 to 10; aa is an integer from 0 to 20; ab is an integer from 0 to 20; ac is an integer from 1 to 20; ae is an integer from 0 to 1; with the proviso that when Rc is an alkoxy, ae is 1, and when Rc is an alkyl, ae is zero.

[0098] More specifically, when Re is an alkoxy, it represents the formula —Rq-O—, wherein Rq represents a C₁-C₆alkyl (and, in particular, is identical to Rp).

[0099] It has been experimentally observed (see examples below) that the first surfactant (I) works synergistically with second surfactant (IX) so as to surprisingly permit the composition to have a lower contact angle. Please note that these results are reached with relatively low concentrations of the surfactants. In this respect, it has been supposed that the second surfactant increases migration capacity of the first surfactant towards the impression material surface.

[0100] Moreover, it is important to point out that both the first and the second surfactant (in particular, the second surfactant) are biodegradable and therefore the composition has an environmental impact appreciably more positive with respect to the composition of the state of the art.

[0101] Advantageously but not necessarily, Rfⁱⁱrepresents a C₁-C₄(in particular, C₃-C₄; more in particular, C₄) fluorine containing (in particular, a perfluorinated) alkyl. In addition or alternatively, R⁷represents a C₁-C₂alkyl. In addition or alternatively, Ra represents a C₂alkyl (in particular, an ethyl). In addition or alternatively, Rb represents a C₂alkyl (in particular, an ethyl). In addition or alternatively, Rc is selected in the group consisting of: a C₃-C₅alkyl, a C₂-C₄alkoxy. In addition or alternatively, ax is an integer from 1 to 6 In addition or alternatively, ay is an integer from 1 to 6. In addition or alternatively, aa is an integer from 0 to 12; ab is an integer from 0 to 12. In addition or alternatively, ac is an integer from 1 to 16.

[0102] According to some non-limiting embodiments, Rfⁱⁱrepresents a C₂-C₄fluorine containing (in particular, a perfluorinated) alkyl.

[0103] In addition or alternatively, R⁷represents a C₁-C₂alkyl. In addition or alternatively, ax is an integer from 1 (in particular, from 4) to 6 (in particular, to 5). In addition or alternatively, ay is an integer from 1 (in particular, from 4) to 6 (in particular, to 5).

[0104] According to some non-limiting embodiments, aa is zero. In addition or alternatively, ab is zero. In addition or alternatively, ac is 1. In addition or alternatively, Rc represents a C₃-C₅alkyl. In addition or alternatively, ae is zero.

[0105] According to some non-limiting embodiments, ax plus ay is from 4 (in particular, from 5) to 8 (in particular, to 7). In addition or alternatively, ac is from 10 (in particular, from 14) to 20 (in particular, to 18); in some specific case, ac is 16. In addition or alternatively, Rc is C₃-C₄alkoxy (more precisely, —CH₂—CH(CH₃)—O—).

[0106] In particular, in the formula (IX) the sum of ax and ay is an integer from 4 to 6.

[0107] According to some specific and non-limiting embodiments, the second surfactant comprises (is) a (at least one) a compound having a formula selected from the group consisting of:

[0108]

- [0109] wherein the sum of ax and ay is an integer from 4 to 6.

[0110] In some non-limiting cases, the second surfactant comprises (is) a (at least one) compound having a formula selected from the group consisting of: (XIII) and (XIV). In more specific non-limiting case, the second surfactant comprises (is) a (at least one) compound having formula (XIII).

[0111] In some specific cases, the second surfactant comprises (is) a surfactant having the following formula:

[0112]

- [0113] more precisely, the second surfactant is Polyfox PF 159 (Omnova Solutions™).

[0114] In addition or alternatively, the second surfactant comprises (is) the surfactant of example 3 (Polyfox PF 7002) reported below.

[0115] Advantageously but not necessarily (in particular, when the second surfactant has the formula (IX)), the curable composition comprises a fluoro compound, which (has) is at least one compound having a formula selected from the group consisting of:

[0116]

- [0117] wherein xx is an integer from 2 to 10; m is an integer from 1 to 20; n is an integer from 0 to 200 (in particular, to 100); Rd are each, independently of one another, selected from a group consisting of: —F, —CF₃.

[0118] It has been experimentally observed (see examples below) that very low concentrations of the fluoro compound works synergistically with first (I) and second surfactants (IX) so as to permit the composition to have a surprisingly low contact angle.

[0119] In particular, up to two Rd are each a —CF₃and the remaining Rd are each —F. More particularly, the two —CF₃are in meta position with respect to each other.

[0120] According to non-limiting embodiments, the fluoro compound is (has) at least one compound having a formula selected from the group consisting of formula (XI) and formula (XII).

[0121] In addition or alternatively, the fluoro compound is (has) at least one compound having the formula (X).

[0122] Advantageously but not necessarily, the curable composition comprises from 0.1% to approximately 3% (in particular, to approximately 1.5%) in weight, with respect to the total weight of the curable composition, of the fluoro compound.

[0123] All the components referred to above should be combined together in a specific way so as to carry out a material for impression taking, having the necessary rheologic, mechanical, bio-compatibility properties.

[0124] In accordance with a second aspect of the present invention, there is provided a use of the curable composition according to the first aspect of the present invention for taking a mold of at least a part of a mouth. In particular, the use comprises contacting the curable composition with at least a part of the mouth.

[0125] In accordance with a third aspect of the present invention, there is provided a method of taking an impression comprising contacting said curable composition according to the first aspect of the present invention with at least a part of a mouth.

[0126] The viscosity measurements are considered to be carried out in accordance to the following. The viscosities are and were measured using a Brookfield viscometer DVII. The measurement is performed at 23° C. and 20 rpm of the spindle. An ULA spindle is and was used with a viscosity in the range 20-200 cP. The spindle SC4-21 is and was used with a viscosity in the range 500-1000 cP. The spindle SC4-29 is and was used with a viscosity in the range 2000-20000 cP, The spindle SC4-29 is and was used with a viscosity in the range 50000-100000 cP.

[0127] The viscosity measurements are and were carried out in accordance to what provided by standard DIN EN ISO 3219:1993 (in particular, on the basis of DIN 53019-1).

[0128] Unless explicitly indicated to the contrary, the content of the references (articles, books, patent applications, etc.) cited in this text is herein referred to in full. In particular, the cited references are herein incorporated by reference.

[0129] Further characteristics of the present invention will be apparent from the following description of purely illustrative and non-limiting examples.

Example 1

[0130] This example discloses the procedure followed for the measurement of the contact angles (sessile drop technique).

[0131] A distilled water drop was put on the hardened silicone surface, 50 μm thick, at the following environment conditions: temperature 23±1° C. and relative humidity 50±10%.

[0132] A video was registered using the Kruss DSA30, filming the drop deposition.

[0133] The measurement was performed after 5 and 30 seconds starting from the deposition.

[0134] The compositions tested in examples from 2 to 15 and had the following components.

[0135]


ADDITION SILICONES	Base	Catalyst

COMPONENTS:
Polyvinylsiloxane	31.25%	57.29%
Micronized quartz (1-10 μm)	52.08%	42.69%
Methylhydrogensiloxane	15.63%
Platinum catalyst		0.02%
Pigments	0.52%
Flavors	0.52%
Surfactant	s weight phr	t weight phr

[0136] Polyvinylsiloxane had the following viscosities: 200 cP (15% with respect to base plus catalyst, 0.28 mmol/g vinyl content), 1000 cP (5% with respect to Base plus Catalyst, 0.127 mmol/g vinyl content), 2000 cP (20% with respect to Base plus Catalyst, 0.097 mmol/g vinyl content), 20000 cP (5% with respect to base plus catalyst, 0.04 mmol/g vinyl content).

[0137] Methylhydrogensiloxane had a viscosity of 60 cP and 1.7 mmol/g as SiH content.

[0138] Platinum catalyst was Karstedt catalyst (CAS Number 68478-92-2).

[0139] The components mixing was performed using the following working instruction.

[0140] Firstly, the Base prepared using a vertical mixer with a cowless (sawblade impeller): pigments were dispersed in Polyvinylsiloxane for 5 minutes; thereafter, quartz and fumed silica were added and mixed for 20 minutes. During this last step, also the flavors were added and mixed for 10 minutes.

[0141] The Catalyst was prepared using a vertical mixer with a cowless (sawblade impeller): pigments were dispersed in Methylhydrogensiloxane for 5 minutes; and then quartz and fumed silica were added and mixed for 20 minutes. During the last step, the Platinum catalyst was added and mixed for 10 minutes.

[0142] Afterwards, using a disperser with a cowless (sawblade impeller) the surfactant was added to the blends described above and mixed for a total of 15 minutes.

[0143] The surfactant was added between 3 weight phr (parts per hundred rubber/resin—in weight) and 6.4 weight phr to both the blends (s and t from 3 to 6.4 weight phr). The phr is to be considered with respect to the weight of all the other components/ingredients of the composition/blend. For example, if the surfactant had 6.4 weight phr, the total weight of the composition would be 106.4 and the ratio of the weight of the surfactant with respect of the total weight of the composition would 6.4/106.4 (corresponding to about 6 wt %).

[0144] Afterwards, the Base and the Catalyst obtained after the addition of the surfactant were introduced in a 50 ml cartridge (25 ml of Base and 25 ml of Catalyst, 1:1), mixing was therefore performed using a dispenser and mixing tip for each example.

[0145] The compositions tested the examples 16 to 19 had the following components.

[0146]


CONDENSATION SILICONES	Base	Catalyst

COMPONENTS:
Polysiloxane hydroxy terminated	60.50%
Micronized quartz (1-10 μm)	38.50%
Alkoxysilanes		70.00%
Tin catalyst		29.00%
Pigments	0.5%	0.5%
Flavours	0.5%	0.5%
Surfactant	s weight phr	t weight phr

[0147] Polysiloxane hydroxy terminated had the following viscosities: 2000 cP (25% with respect to the base), 5000 cP (35.5% with respect to the base).

[0148] Silicon dioxide was quartz and fumed silica.

[0149] Alkoxysilane was Tetrakis-(butoxy-ethoxy)silane —(CH₃—(CH₂)₃—O—(CH₂)₂—O)₄—Si.

[0150] Tin catalyst was Dioctyltin oxide.

[0151] The components mixing was performed using the following working instruction.

[0152] Firstly, the Base was prepared using a vertical mixer with a cowless: pigments were dispersed in Polysiloxane hydroxy terminated in 5 minutes, then quartz and fumed silica were added and mixed for 20 minutes. During this last step, the flavors were added and mixed for 10 minutes (the last 5 minutes under vacuum).

[0153] Secondly, the Catalyst was prepared in the following way: hydrocarbons were melted in a reactor at 90° C. and mixed with pigments for a total period of 3 hours, then alkoxysilanes and flavours were added and mixed for 1 hour.

[0154] Afterwards, using a disperser with a cowless, the surfactant was added to the blends described above and mixed for a total of 15 minutes.

[0155] The surfactant was added with a percentage between 1 weight phr and 2.5 weight phr (s and t from 1 to 2.5 weight phi).

[0156] At the end, Base was introduced in a 14 ml tube and Catalyst in a 60 ml tube for each example.

[0157] Mixing was performed by, hands using a spatula and dosing Base and Catalyst with a weight ratio 10:0.32 for each example.

Example 2 (Comparative)

[0158] The surfactant was 3 weight phr Silwet L77 (Momentive™), which had the formula:

[0159]

[0160] where R and R³was —CH₃, R¹was —C₃H₆—, R²was hydrogen, x was 0 or 1, y was 1 or 2, a was about 7 and b was 0. The contact angle was 33.7° at 5 seconds and 15.5° at 30 seconds.

[0161] This example was used as a reference for the examples from 3 to 16.

Example 3

[0162] The surfactant was 3 weight phr Silwet L77 and 1 weight phr Polyfox PF 7002 (Omnova Solutions™), whose structure was the following one:

[0163]

[0164] The contact angle was 37.1° at 5 seconds and 11.5° at 30 seconds.

[0165] The performances improved with respect to the reference (example 2) at 5 seconds, while there was a little contact angle reduction at 30 seconds.

Example 4

[0166] The surfactant was 3 weight phr Silwet L77, 1 weight phr Polyfox PF 7002 and 1 weight phr Fluorosil D2 (Siltech™), whose structure was the one below, with x=3, m was between 0 and 20 and n was between 1 and 200:

[0167]

[0168] The contact angle was 22.3° at 5 seconds and 10.3° at 30 seconds.

[0169] The composition had a better contact angle than the example 3, where Polyfox PF 7002 was alone together with Silwet L77.

Example 5

[0170] The surfactant was 3 weight phr Silwet L77, 1 weight phr Polyfox PF 7002 and 0.5 weight phr Perfluorodecalin, whose structure was the following one:

[0171]

[0172] The contact angle was 24.9° at 5 seconds and 6.9° at 30 seconds.

[0173] The fluorinated compound led the composition to have a better contact angle than that of the example 3, where Polyfox PF 7002 was alone together with Silwet L77.

Example 6

[0174] The surfactant was 3 weight phr Silwet L77, 1 weight phr Polyfox PF 7002 and 0.2 weight phr Perfluoro-1,3-dimethylcyclohexane, whose was the following one:

[0175]

[0176] The contact angle was 27.5° at 5 seconds and 8.3° at 30 seconds.

[0177] The composition had a better contact angle than that of example 3, where Polyfox PF 7002 was alone together with Silwet L77.

Example 7

[0178] The surfactant was 3 weight phr Silwet L77, 1 weight phr Polyfox PF 7002 and 0.5 weight phr Perfluoro-1,3-dimethylcyclohexane (see above).

[0179] The contact angle was 24.6° at 5 seconds and 7.8° at 30 seconds.

[0180] The composition had a better contact angle than that of example 3, where Polyfox PF 7002 was alone together with Silwet L77. The increase in Perfluoro-1,3-dimethylcyclohexane quantity did not have a significant effect on the contact angle reduction.

Example 8

[0181] The surfactant was 3 weight phr Silwet L77, 1 weight phr Polyfox PF 7002 and 0.8 weight phr Perfluoro-1,3-dimethylcyclohexane (see above).

[0182] The contact angle was 25.4° at 5 seconds and 7.8° at 30 seconds.

[0183] The composition had a better contact angle than that of example 3, where Polyfox PF 7002 was alone together with Silwet L77. The increase in Perfluoro-1,3-dimethylcyclohexane quantity did not have a significant effect on the contact angle reduction.

Example 9

[0184] The surfactant was 3 weight phr Silwet L77 and 1 weight phr Tivida FL2500 (Merck™) (whose structure was the one below, wherein k, j, z, r, d and t were each, independently of one another, an integer from 1 to 10; Rf were each, independently of one another, a C₁-C₆fluorine containing alkyl.

[0185]

[0186] The contact angle was 21.3° at 5 seconds and 1.7° at 30 seconds. The performances were better than the reference (example 2), especially at 30 seconds.

Example 10

[0187] The surfactant was 3 weight phr Silwet L77 and 3.4 weight phr Tivida FL2500 (Merck™) (whose structure was the one below, wherein k, j, z, r, d and t were each, independently of one another, an integer from 1 to 10; Rf were each, independently of one another, a C₁-C₆fluorine containing alkyl).

[0188]

[0189] The contact angle was 6.5° at 5 seconds and 1.4° at 30 seconds. The performances were significantly better than the reference (example 2), even at 5 seconds.

Example 11

[0190] The surfactant was 3 weight phr Silwet L77 and 3.4 weight phr Tivida FL2300 (Merck™) (whose structure was the one below, wherein k, j, z, r, d and t were each, independently of one another, an integer from 1 to 10; Rf were each, independently of one another, a C₁-C₆fluorine containing alkyl).

[0191]

[0192] The contact angle was 29.1° at 5 seconds and 8.7° at 30 seconds. The performances were better than the reference (example 2).

Example 12

[0193] The surfactant was 3 weight phr Silwet L77 and 1 weight phr Tivida FL3000 (Merck™) (whose structure was the one below; wherein q was an integer from 1 to 20 and Rfⁱwere each, independently of one another, selected from a group consisting of: CF₃—CF₂—CF₂—O—CF(CF₃)—CH₂— and CF₃—(CF₂)_e—(CH₂)_f—, wherein e was an integer from 1 to 7 and f was an integer from 1 to 10).

[0194]

[0195] The contact angle was 9.4° at 5 seconds and 6.4° at 30 seconds. The performances were significantly better than the reference (example 2), even at 5 seconds.

Example 13 (Comparative)

[0196] The surfactant was 3 weight phr Silwet L77 and 1 weight phr FluorN 561 (Cytonix™) (whose structure contains 4 groups pendant from a matrix based on polypropylene glycol: 2 perfluoro and 2 polyethylene glycol).

[0197] The contact angle was 46° at 5 seconds and 18.4° at 30 seconds. The performances were worse than the reference (example 2).

Example 14 (Comparative)

[0198] The surfactant was 3 weight phr Silwet L77 and 1 weight phr FluorN 562 (Cytonix™) (whose structure contains 4 groups pendant from a matrix based on polypropylene glycol: 1 perfluoro and 3 polyethylene glycol).

[0199] The contact angle was 42.1° at 5 seconds and 16.4° at 30 seconds. The performances were worse than the reference (example 2).

Example 15 (Comparative)

[0200] The surfactant was 3 weight phr Silwet L77 and 1 weight phr FluorN 2900 (Cytonix) (whose structure was a perfluoroethylene with a high molecular weight, glycol terminated).

[0201] The contact angle was 29.5° at 5 seconds and 13.1° at 30 seconds. The performances were not better than the reference (example 2).

Example 16 (Comparative)

[0202] The surfactant was 1 weight phr Silwet L77 (Momentive), which had the following formula:

[0203]

- [0204] where R and R³was —CH₃, R¹was —C₃H₆—, R²was hydrogen, x was 0 or 1, y was 1 or 2, a was about 7 and b was 0. The contact angle was 52.9% at 5 seconds and 35.8° at 30 seconds.

[0205] This example was used as a reference for the examples from 17 to 19.

Example 17

[0206] The surfactant was 1 weight phr Silwet L77 and 1 weight phr Tvida FL3000 (Merck) (whose structure was the one below; wherein q was an integer from 1 to 100 and Rfⁱwere each, independently of one another, selected from a group consisting of: CF₃—CF₂—CF₂—O—CF(CF₃)—CH₂— and CF₃—(CF₂)_e—(CH₂)_f—, wherein e was an integer from 1 to 7 and m was an integer from 1 to 10).

[0207]

[0208] The contact angle was 25.4° at 5 seconds and 16.4° at 30 seconds. The performances were significantly better than the reference (example 16), even at 5 seconds.

Example 18 (Comparative)

[0209] The surfactant was 1 weight phr Silwet L77 and 1 weight phr Polyfox PF 7002 (Omnova Solutions) (whose structure was the one below).

[0210]

[0211] The contact angle was 52.1° at 5 seconds and 31.5° at 30 seconds.

[0212] The performances were slightly better than the reference (example 16).

Example 19

[0213] The surfactant was 1 weight phr Silwet L77, 1 weight phr Polyfox PF 7002 and 0.5 weight phr Perfluorodecalin (whose structure was the one below below).

[0214]

[0215] The contact angle was 27.2° at 5 seconds and 19.5° at 30 seconds.

[0216] The fluorinated compound led the composition had a better contact angle than the example 18, where Polyfox PF 7002 was alone together with Silwet L77.

[0217] While the principles of the invention have been explained in relation to certain embodiments, it is to be understood that various modifications thereof will become apparent to those skilled in the art upon reading the specification. Therefore, it is to be understood that the invention disclosed herein is intended to cover such modifications as fall within the scope of the appended claims. The scope of the invention is limited only by the scope of the appended claims.

Claims

Certificate of Correction present

The claims shown below may not include correction changes. Use the corrected PDF for authoritative text.

The invention claimed is:

1. A curable composition for dental impression comprising:

a curable base composition and

a surfactant system comprising a first surfactant, which is at least one compound having the following formula (I)

wherein R are each, independently of one another, a C₁-C₄aliphatic;

each R¹is, independently of the others, a C₁-C₆aliphatic; each R²is, independently of the others, selected from a group consisting of: H and C₁-C₃aliphatic; each R³is selected, independently of the others, from a group consisting of: H and C₁-C₄aliphatic; x is an integer from 0 to 5; y is an integer from 1 to 10; a is an integer from 1 to 30; b is an integer from 0 to 5;

and a second surfactant, which is at least one compound having the following formula (II):

wherein R⁴is selected from a group consisting of:

R⁵is selected from a group consisting of:

and

R⁶is selected from a group consisting of:

wherein k, j, z, r, d and t are each, independently of one another, an integer from 1 to 10; q is an integer from 1 to 100; Rf are each, independently of one another, a C₁-C₆fluorine containing alkyl; and Rf are each, independently of one another, selected from a group consisting of: CF₃—CF₂—CF₂—O—CF(CF₃)—CH₂— and CF₃—(CF₂)_e—(CH₂)f-, wherein e is an integer from 1 to 7 and f is an integer from 1 to 10,

wherein the curable composition comprises from approximately 0.1% to approximately 7% in weight, with respect to approximately the total weight of the curable composition, of the first surfactant and from approximately 0.1% to approximately 7% in weight, with respect to the total weight of the curable composition, of the second surfactant,

the curable composition further comprising from 0.1% to 3% in weight with respect to the total weight of the curable composition of a fluoro compound, which is at least one compound having a formula selected from the group consisting of the following formulae:

2. The curable composition according to claim 1, wherein each R is a methyl;

each R¹is —C₃H₆—; each R²is an H; each R³is selected, independently of the others, from a group consisting of: H and methyl; x is an integer from 0 to 1; y is an integer from 1 to 5; a is an integer from 5 to 20; b is zero;

k, j, z, r, d and t are each, independently of one another, an integer from 1 to 6; q is an integer from 1 to 40; Rf are each, independently of one another, a C₁-C₄fluorine containing alkyl; and Rfⁱare each, independently of one another, selected from a group consisting of: CF₃—CF₂—CF₂—O—CF(CF₃)—CH₂—, CF₃—(CF₂)₂—(CH₂)— and CF₃—(CF₂)—(CH₂)—.

3. The curable composition according to claim 1, wherein R⁴represents:

R⁵represents:

and

R⁶represents:

4. A curable composition according to claim 1, wherein R⁴represents:

R⁵represents:

and

R⁶represents:

5. A curable composition for dental impression comprising:

a curable base composition

a surfactant system comprising a first surfactant, which is at least one compound having the following formula (I)

wherein R are each, independently of one another, a C₁-C₄aliphatic;

a second surfactant, which is at least one compound having the following formula (IX):

wherein Rfⁱⁱrepresents a C₁-C₆fluorine containing alkyl; R⁷represents a C₁-C₄alkyl; Ra represents a C₁-C₃alkyl; Rb represents a C₁-C₃alkyl; Rc is selected in the group consisting of: a C1-C6 aliphatic, a C₁-C₆alkoxy; Rp represents a C₁-C₆alkyl; ax is an integer from 1 to 10; ay is an integer from 1 to 10; aa is an integer from 0 to 20; ab is an integer from 0 to 20; ac is an integer from 1 to 20; ae is an integer from 0 to 1; with the proviso that when Rc is an alkoxy, ae is 1, and when Rc is an alkyl, ae is zero; and

a fluoro compound, which is at least one compound having a formula selected from the group consisting of:

wherein xx is an integer from 2 to 10; m is an integer from 1 to 20; n is an integer from 0 to 200; Rd are each, independently of one another, selected from a group consisting of: —F, —CF₃.

6. The curable composition according to claim 5, wherein Rfⁱⁱrepresents a C₁-C₄fluorine containing alkyl; R⁷represents a C₁-C₂alkyl; Ra represents an ethyl; Rb represents an ethyl; Rc is selected in the group consisting of: a C₃-C₅alkyl, a C₂-C₄alkoxy; ax is an integer from 1 to 6; ay is an integer from 1 to 6; aa is an integer from 0 to 12; ab is an integer from 0 to 12; ac is an integer from 1 to 16.

7. The curable composition according to claim 5, wherein Rfⁱⁱrepresents a C₂-C₄fluorine containing alkyl; R⁷represents a C₁-C₂alkyl; Re represents a C₃-C₅alkyl; ax is an integer from 1 to 5; ay is an integer from 1 to 5; aa is zero; ab is zero; ac is 1; ae is zero.

8. The curable composition according to claim 5, wherein the fluoro compound is at least one compound having a formula selected from the group consisting of formula (XI) and formula (XII), wherein up to two Rd are each a —CF₃and the remaining Rd are each —F; with the proviso that, the two Rd that are each a —CF₃are in meta position with respect to each other.

9. The curable composition according to claim 1, wherein the curable base composition comprises a first component, comprising a curable organopolysiloxane polymer; a second component, comprising a crosslinker compound capable of crosslinking said organopolysiloxane polymer; a third component, comprising a catalyst capable of catalyzing a crosslinking reaction of the first component and the second component.

10. The curable composition according to claim 9, wherein the curable base composition comprises a first component, comprising an organopolysiloxane with at least two ethylene unsaturated groups; a second component, comprising an organohydrogen siloxane and/or an organopolysiloxane with Si—H groups; and, the third component is a Platinum comprising catalyst.

11. The curable composition according to claim 9, wherein the curable base composition comprises a first component, comprising a polysiloxane hydroxy terminated; a second component comprising an alkoxysilane; and, the third component is a Tin comprising catalyst.

12. A curable composition, for use in taking a mold of at least a part of a mouth, comprising:

a curable base composition and

a surfactant system comprising a first surfactant, which is at least one compound having the following formula (I)

wherein R are each, independently of one another, a C₁-C₄aliphatic: each R¹is, independently of the others, a C₁-C₆aliphatic; each R²is, independently of the others, selected from a group consisting of; H and C₁-C₃aliphatic; each R³, is selected, independently of the others, selected from a group consisting of: H and C₁-C₄aliphatic: x is an integer from 0 to 5: v is an integer from 1 to 10: a is an integer from 1 to 30; b is an integer from 0 to 5; and

a second surfactant, which is at least one compound having the following formula (II):

wherein R⁴is selected from a group consisting of:

R⁵is selected from a group consisting of:

and

R⁶is selected from a group consisting of:

wherein k, j, z, r, d and t are each, independently of one another, an integer from 1 to 10; q is an integer from 1 to 100; Rf are each, independently of one another, a C₁to C₆fluorine containing alkyl; and Rf are each, independently of one another, selected from a group consisting of: CF₃—CF₂—CF₂—O—CF(CF₃)—CH₂— and CF₃—(CF₂)_e—CH₂)_f, wherein e is an integer from 1 to 7 and f is an integer from 1 to 10;

a fluoro compound, which is at least one compound having a formula selected from the group consisting of:

wherein xx is an integer from 2 to 10; m is an integer from 1 to 20; n is an integer from 0 to 200; Rd are each, independently of one another, selected from a group consisting of: —F, —CF₃;

13. A method of taking an impression comprising contacting a curable composition with at least a part of a mouth, the composition comprising a curable base composition and a surfactant system comprising a first surfactant, which is at least one compound having the following formula (I)

wherein R are each, independently of one another, a C₁-C₄aliphatic; each R¹is, independently of the others, a C₁-C₆aliphatic; each R²is, independently of the others, selected from a group consisting of: H and C₁-C₃aliphatic; each R³is selected, independently of the others, from a group consisting of: H and C₁-C₄aliphatic; x is an integer from 0 to 5; y is an integer from 1 to 10; a is an integer from 1 to 30; b is an integer from 0 to 5;

and a second surfactant, which is at least one compound having the following formula (II):

wherein R⁴is selected from a group consisting of:

R⁵is selected from a group consisting of:

and

R⁶is selected from a group consisting of:

wherein k, j, z, r, d and t are each, independently of one another, an integer from 1 to 10; q is an integer from 1 to 100; Rf are each, independently of one another, a C₁-C₆fluorine containing alkyl; and Rf are each, independently of one another, selected from a group consisting of: CF₃—CF₂—CF₂—O—CF(CF₃)—CH₂— and CF₃—(CF₂)_e—CH₂)_f, wherein e is an integer from 1 to 7 and f is an integer from 1 to 10;

a fluoro compound, which is at least one compound having a formula selected from the group consisting of:

wherein xx is an integer from 2 to 10; m is an integer from 1 to 20; n is an integer from 0 to 200; Rd are each, independently of one another selected from a group consisting of: —F, —CF₃,

14. The curable composition of claim 5, wherein n is an integer from 0 to 100.

Patent Citations (33)

Patent	Date	Inventor	Cited By
US4389496(A)	1983-06-01	Leuesner	Applicant
US4657959(A)	1987-04-01	Bryan	Applicant
US5925723(A)	1999-07-01	Friebe	Applicant
US6218461(B1)	2001-04-01	Schwabe	Applicant
US7592377(B2)	2009-09-01	Rossi	Applicant
US7812065(B2)	2010-10-01	Bublewitz	Applicant
US8466210(B2)	2013-06-01	Zech	Applicant
US8916623(B2)	2014-12-01	Riedel	Examiner
US9549881(B2)	2017-01-01	Osswald	Examiner
US2008/0319100(A1)	2008-12-01	Bublewitz	Applicant
US2010/0292362(A1)	2010-11-01	Zech et al.	Applicant
US2011/0118378(A1)	2011-05-01	Bublewitz	Applicant
US2013/0269568(A1)	2013-10-01	Claus	Applicant
US2017/0217863(A1)	2017-08-01	Friedrich	Applicant
US2017/0296443(A1)	2017-10-01	Angeletakis	Applicant
US2019/0240118(A1)	2019-08-01	Angeletakis	Applicant
CA3161425	2021-05-01		Applicant
CN105199110	2015-12-01		Applicant
CN115151232	2022-10-01		Applicant
DE4137698(A1)	1993-05-01		Applicant
DE112007000073(A5)	2008-10-01		Applicant
EP2231102(B1)	2011-09-01		Applicant
EP1976479(B1)	2011-11-01		Applicant
EP3824868	2021-05-01		Applicant
EP4061308	2022-09-01		Applicant
JP2004535485	2004-11-01		Applicant
JP2011506612	2011-03-01		Applicant
JP2013159614(A)	2013-08-01		Applicant
JP2014510021	2014-04-01		Applicant
JP2016069590	2016-05-01		Applicant
JP2023502479	2023-01-01		Applicant
WO2009079534(A2)	2009-06-01		Applicant
WO2021099462	2021-05-01		Applicant

Non-Patent Literature (17)

Omnova Solutions, PolyFoxTM PF-636, PF-656, PF-6320 & PF-6520: Fluorosurfactant Diols for Improved Flow, Leveling and Surface Appearance in Solvent-Borne Coatings, Jun. 2011, p. 1-3 (Year: 2011).Examiner
International Search Report; PCT/EP2020/082681; Nov. 30, 2020 (completed); Dec. 8, 2020 (mailed).Applicant
International Preliminary Report on Patentability; PCT/EP2020/082681; Nov. 30, 2020 (completed); Dec. 8, 2020 (mailed).Applicant
Written Opinion of the International Searching Authority; PCT/EP2020/082681; Nov. 30, 2020 (completed); Dec. 8, 2020 (mailed).Applicant
Svitova et al.; “Wetting and Interfacial Transitions in Dilute Solutions of Trisiloxane Surfactants”; Institute of Physical Chemistry, Russian Academy of Sciences, Moscow, Russia, Dow Corning Corp., Midland, Michigan, 48686, and University of Bayreuth, Bayreuth, Germany; , 1998, 14, 5023-5031.Applicant
Chinese Office Action dated Aug. 31, 2023 (English Translation).Applicant
Kovalchuk et al.; “Fluror vs Hydrocarbon surfactants: why do they differ in wetting performance?”; Advance in Colloid and Interface Science; vol. 210 (2014); pp. 65-71.Applicant
“Canadian Application Serial No. 3,161,425, Examiners Rule 86(2) Report mailed Sep. 4, 2024”, 4 pgs.Applicant
“Japanese Application Serial No. 2022-529552, Notification of Reasons for Refusal mailed Oct. 16, 2024”, w English translation, 8 pgs.Applicant
“Canadian Application Serial No. 3,161,425, Office Action mailed Aug. 21, 2023”, 5 pgs.Applicant
“Canadian Application Serial No. 3,161,425, Response filed Nov. 10, 2023 to Office Action mailed Aug. 21, 2023”, 26 pgs.Applicant
“European Application Serial No. 19210349.7, Invitation to remedy deficiencies mailed Nov. 16, 2023”, 3 pgs.Applicant
“European Application Serial No. 19210349.7, Response filed Nov. 23, 2023 to Invitation to remedy deficiencies mailed Nov. 16, 2023”, 1 pg.Applicant
“Japanese Application Serial No. 2022-529552, Notification of Reasons for Refusal mailed Mar. 6, 2025”, w English translation, 6 pgs.Applicant
“Japanese Application Serial No. 2022-529552, Response filed Jun. 4, 2025 to Notification of Reasons for Refusal mailed Mar. 6, 2025”, w English Claims, 16 pgs.Applicant
“Chinese Application Serial No. 202080081037.5, Office Action mailed Aug. 31, 2023”, W English Translation, 21 pgs.Applicant
“Chinese Application Serial No. 202080081037.5, Office Action mailed Mar. 28, 2024”, W English Translation, 10 pgs.Applicant

Abstract

Description

FIELD OF THE INVENTION

[0001] The present invention relates to a curable composition for dental impression and a use thereof. The present invention also relates to a method of taking an impression.

BACKGROUND OF THE INVENTION

[0005] Fillers and additives are typically added both to addition and condensation silicones to improve their mechanical performances or get specific organoleptic properties.

[0008]

was reported in U.S. Pat. No. 4,657,959.

[0010] The efficacy as a superspreader is lower when it is englobed in a matrix. This is caused by the lower migration capacity towards the impression material surface.

Objective of the Present Invention

SUMMARY OF THE INVENTION

[0019] Unless explicitly specified to the contrary, the following terms have the meaning indicated below.

[0021] In the present text, C_x-C_yrefers to a group that is meant as having from x to y carbon atoms.

[0024] In the present text, “alkoxy” means an alkyl containing an oxygen which is bonded to two carbons.

DETAILED DESCRIPTION OF THE INVENTION

[0025] In accordance with a first aspect of the present invention, there is provided a curable composition for dental impression comprising:

- [0026] a curable base composition and a surfactant system comprising a first surfactant, which has (is at least one compound having) the following formula (I)

[0027]

- [0028] wherein R are each, independently of one another, a C₁-C₄aliphatic; (each) R¹is (independently of the others) a C₁-C₆aliphatic; (each) R²is (independently of the others) selected from a group consisting of: H and C₁-C₃aliphatic; (each) R³is selected (independently of the others) from a group consisting of: H and C₁-C₄aliphatic; x is an integer from 0 to 5; y is an integer from 1 to 10; a is an integer from 1 to 30; b is an integer from 0 to 5.

[0030] The surfactant system further comprises a second surfactant, which, according to some non-limiting embodiments, has (is at least one compound having) the following formula (II):

[0031]

- [0032] wherein R⁴is selected from a group consisting of:

[0033]

- [0034] R⁵is selected from a group consisting of:

[0035]

- [0036] and
- [0037] R⁶is selected from a group consisting of:

[0038]

- [0039] wherein k, j, z, r, d and t are each, independently of one another, an integer from 1 to 10; q is an integer from 1 to 100; Rf are each, independently of one another, a C₁-C₆fluorine containing alkyl (in particular, a perfluorinated alkyl); and Rfⁱare each, independently of one another, selected from a group consisting of: CF₃—CF₂—CF₂—O—CF(CF₃)—CH₂— and CF₃—(CF₂)_e—(CH₂)_f—, wherein e is an integer from 1 to 7 and f is an integer from 1 to 10.